This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback
Trial record 16 of 17 for:    "Fibrous Dysplasia of Bone"

Natural History of Cherubism Observational Study

This study has been completed.
Information provided by (Responsible Party):
The Cleveland Clinic Identifier:
First received: July 25, 2013
Last updated: January 6, 2017
Last verified: January 2017
To observe the natural history of cherubism.

Condition Intervention
Cherubism Other: no interventions

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Natural Hisotry of Cherubism Observational Study

Resource links provided by NLM:

Further study details as provided by The Cleveland Clinic:

Primary Outcome Measures:
  • Disease progression [ Time Frame: 10 years ]
    We will take a history and examine patients with cherubism and look for disease progression.

Secondary Outcome Measures:
  • patient growth [ Time Frame: 10 years ]
    We will measure height and weight

  • bone abnormalities [ Time Frame: 10 years ]
    We will take panorex radiographs.

Biospecimen Retention:   Samples With DNA
We may take blood or skin samples.

Enrollment: 33
Study Start Date: July 2013
Study Completion Date: September 2016
Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
cherubism patients
no interventions
Other: no interventions
no interventions

Detailed Description:
The investigators will take a history and examine patients with cherubism to determine the natural history of the disease. The investigators also may take skin or blood samples (IRB approved 7256) from patients to learn more about this disorder.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
We will see patients with cherubism

Inclusion Criteria:

patients with cherubism

Exclusion Criteria:

patients without cherubism

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01916772

United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Sponsors and Collaborators
The Cleveland Clinic
Principal Investigator: Steven Lietman The Cleveland Clinic
  More Information

Responsible Party: The Cleveland Clinic Identifier: NCT01916772     History of Changes
Other Study ID Numbers: CCFO7256
Study First Received: July 25, 2013
Last Updated: January 6, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is no plan to share IPD.

Keywords provided by The Cleveland Clinic:
bone tumors

Additional relevant MeSH terms:
Fibrous Dysplasia of Bone
Bone Diseases, Developmental
Bone Diseases
Musculoskeletal Diseases
Jaw Diseases
Stomatognathic Diseases
Maxillofacial Abnormalities
Craniofacial Abnormalities
Musculoskeletal Abnormalities
Congenital Abnormalities
Genetic Diseases, Inborn processed this record on August 18, 2017